BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 11692091)

  • 21. Respiratory syncytial virus infection in a murine model of cystic fibrosis.
    Colasurdo GN; Fullmer JJ; Elidemir O; Atkins C; Khan AM; Stark JM
    J Med Virol; 2006 May; 78(5):651-8. PubMed ID: 16555274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BuShenYiQi Formula strengthens Th1 response and suppresses Th2-Th17 responses in RSV-induced asthma exacerbated mice.
    Wang J; Wu J; Kong L; Nurahmat M; Chen M; Luo Q; Li B; Wu X; Dong J
    J Ethnopharmacol; 2014 May; 154(1):131-47. PubMed ID: 24704667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Respiratory syncytial virus-induced acute and chronic airway disease is independent of genetic background: an experimental murine model.
    Chávez-Bueno S; Mejías A; Gómez AM; Olsen KD; Ríos AM; Fonseca-Aten M; Ramilo O; Jafri HS
    Virol J; 2005 May; 2():46. PubMed ID: 15916706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effects of respiratory syncytial virus infection on T-helper cytokines expression in Balb/c mice sensitized with ovalbumin].
    Zou Y; Xu J; Zhong N
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Aug; 25(8):470-4. PubMed ID: 12425832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Respiratory syncytial virus persistence: evidence in the mouse model.
    Mejías A; Chávez-Bueno S; Gómez AM; Somers C; Estripeaut D; Torres JP; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S60-2. PubMed ID: 18820580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of effect of bovine lactoferrin in respiratory syncytial virus replication and clinical disease severity in the mouse model.
    Gualdi L; Mertz S; Gomez AM; Ramilo O; Wittke A; Mejias A
    Antiviral Res; 2013 Aug; 99(2):188-95. PubMed ID: 23735300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Respiratory syncytial virus persistence in the lungs correlates with airway hyperreactivity in the mouse model.
    Estripeaut D; Torres JP; Somers CS; Tagliabue C; Khokhar S; Bhoj VG; Grube SM; Wozniakowski A; Gomez AM; Ramilo O; Jafri HS; Mejias A
    J Infect Dis; 2008 Nov; 198(10):1435-43. PubMed ID: 18828742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of intercellular adhesion molecule-1 in a murine model of toluene diisocyanate-induced asthma.
    Furusho S; Myou S; Fujimura M; Kita T; Yasui M; Kasahara K; Nakao S; Takehara K; Sato S
    Clin Exp Allergy; 2006 Oct; 36(10):1294-302. PubMed ID: 17014439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Remodeling associated expression of matrix metalloproteinase 9 but not tissue inhibitor of metalloproteinase 1 in airway epithelium: modulation by immunostimulatory DNA.
    Cho JY; Miller M; McElwain K; McElwain S; Shim JY; Raz E; Broide DH
    J Allergy Clin Immunol; 2006 Mar; 117(3):618-25. PubMed ID: 16522462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timing of infection and prior immunization with respiratory syncytial virus (RSV) in RSV-enhanced allergic inflammation.
    Barends M; Van Oosten M; De Rond CG; Dormans JA; Osterhaus AD; Neijens HJ; Kimman TG
    J Infect Dis; 2004 May; 189(10):1866-72. PubMed ID: 15122523
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of CD8+ T lymphocytes attenuates respiratory syncytial virus-enhanced allergic inflammation.
    Jiang XB; Wang ZD; Zhu Y; Zhang XL; Cui XF; Yao K; Yin KS
    Respiration; 2009; 77(1):76-84. PubMed ID: 18818487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model.
    Li L; Yu CH; Ying HZ; Yu JM
    J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Respiratory syncytial virus enhances respiratory allergy in mice despite the inhibitory effect of virus-induced interferon-gamma.
    Barends M; Boelen A; de Rond L; Dormans J; Kwakkel J; van Oosten M; Neijens HJ; Kimman TG
    J Med Virol; 2003 Jan; 69(1):156-62. PubMed ID: 12436492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alleviation of respiratory syncytial virus replication and inflammation by fungal immunomodulatory protein FIP-fve from Flammulina velutipes.
    Chang YC; Chow YH; Sun HL; Liu YF; Lee YT; Lue KH; Ko JL
    Antiviral Res; 2014 Oct; 110():124-31. PubMed ID: 25131377
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T helper 1 background protects against airway hyperresponsiveness and inflammation in guinea pigs with persistent respiratory syncytial virus infection.
    Sutton TC; Tayyari F; Khan MA; Manson HE; Hegele RG
    Pediatr Res; 2007 May; 61(5 Pt 1):525-9. PubMed ID: 17413871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
    Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
    Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary infection of mice with high titer inoculum respiratory syncytial virus: characterization and response to antiviral therapy.
    Bolger G; Lapeyre N; Dansereau N; Lagacé L; Berry G; Klosowski K; Mewhort T; Liuzzi M
    Can J Physiol Pharmacol; 2005 Feb; 83(2):198-213. PubMed ID: 15791294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol suppresses persistent airway inflammation and hyperresponsivess might partially via nerve growth factor in respiratory syncytial virus-infected mice.
    Zang N; Li S; Li W; Xie X; Ren L; Long X; Xie J; Deng Y; Fu Z; Xu F; Liu E
    Int Immunopharmacol; 2015 Sep; 28(1):121-8. PubMed ID: 26044349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Dingchuantang decoction restores the imbalance of TH2/TH1 in mice infected by respiratory syncytial virus].
    Cui ZZ; Wu ZQ; Wang XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Feb; 8(1):63-5. PubMed ID: 16522244
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of ciclamilast, a new PDE 4 PDE4 inhibitor, on airway hyperresponsiveness, PDE4D expression and airway inflammation in a murine model of asthma.
    Deng YM; Xie QM; Tang HF; Sun JG; Deng JF; Chen JQ; Yang SY
    Eur J Pharmacol; 2006 Oct; 547(1-3):125-35. PubMed ID: 16956605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.